What Is Hexapeptide-12? Definition and What Research Reports
Hexapeptide-12 is an INCI (cosmetic ingredient) name for a laboratory-made peptide built from six amino acids, most often encountered in its fat-modified form, palmitoyl hexapeptide-12, in topical skincare formulations. The "-12" is a registry number, not a measure of strength. Published work on the term is concentrated in cosmetic dermatology and skin-science journals: studies have monitored the palmitoylated peptide in human skin layers, described multi-peptide technologies that include it, and proposed frameworks for evaluating the safety of cosmetic peptides.
Definition
Hexapeptide-12 is an International Nomenclature of Cosmetic Ingredients (INCI) name for a synthetic peptide composed of six amino acids linked in a defined sequence (hexa- meaning six). It is a cosmetic ingredient designation rather than a drug name, and it is most commonly encountered in the literature and on ingredient lists in its lipid-modified form, palmitoyl hexapeptide-12, in which a palmitic acid (a sixteen-carbon fatty acid) chain is attached to the peptide to make the molecule more lipophilic. The trailing number is a sequential registry designation that separates this entry from other six-amino-acid INCI entries such as hexapeptide-8 or hexapeptide-11; it does not indicate potency, generation, or any ranking. In practice, the word appears in three settings: on the ingredient declaration of topical products, in cosmetic-science papers that study how such peptides behave in or on skin, and in reviews of peptide chemistry and cosmetic safety assessment. This page is for educational purposes only and is not medical advice; consult a licensed physician for questions about any ingredient, product, or health condition.
What Class of Molecule It Is
Hexapeptide-12 belongs to the broad category of short synthetic peptides used topically in cosmetics. Peptides in this category are chains of roughly two to ten amino acids produced by chemical synthesis (typically solid-phase peptide synthesis) rather than extracted from animals or plants, and they are often modified after assembly — acetylated, amidated, or acylated with a fatty acid such as palmitic acid — to change how the molecule partitions between water and lipid. That acylation step is why the palmitoylated version dominates the published record: the fatty acid tail alters the molecule's physical behaviour at the skin surface and within the stratum corneum.
Several distinctions are worth holding onto, because the naming convention invites confusion:
- It is a cosmetic ingredient name, not a pharmaceutical name. Unlike drug substances, INCI names carry no approval status and no defined therapeutic indication.
- It is not related by family to numbered peptides that share the "hexapeptide" prefix. Hexapeptide-8 (acetyl hexapeptide-8), hexapeptide-11, and hexapeptide-12 are separate sequences that happen to share a length.
- It is not a hormone, growth factor, or secretagogue. The research peptides discussed elsewhere under those headings are administered systemically in study settings; hexapeptide-12 appears in the literature as a topical formulation ingredient.
- The palmitoylated and unmodified forms are listed separately. "Palmitoyl hexapeptide-12" and "hexapeptide-12" are distinct INCI entries.
Where the Term Comes From
The name originates in cosmetic ingredient nomenclature, where peptides are catalogued by chain length plus a number assigned in order of registration. Short peptides of this type are generally designed in the laboratory — sometimes as sequences related to fragments of structural proteins found in the dermal extracellular matrix, sometimes as sequences selected through screening — and are then manufactured synthetically to a defined purity specification. Because the INCI system names the substance rather than describing its origin or intended function, the label "hexapeptide-12" communicates chemistry and registry position only. Any claim about what the ingredient does has to come from published studies, not from the name.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeHow the Term Is Used in Peptide Research
In the peer-reviewed literature, "hexapeptide-12" is used in a narrow and fairly consistent way. Papers use it as an ingredient identifier when describing the composition of a topical formulation, as an analyte in skin-science experiments that track where a molecule sits within skin layers, and as an example substance in methodological or regulatory discussions of how cosmetic peptides should be assessed. It also appears in descriptions of multi-ingredient peptide technologies, where it is named alongside a second peptide as part of a defined combination.
Readers scanning the literature will notice that most reports operate at the level of the finished formulation rather than the isolated peptide. That is a structural feature of cosmetic dermatology research: products contain many ingredients, and a clinical outcome measured on a formulation cannot be attributed to any single component unless the design isolates it.
What the Published Literature Reports
Monitoring the palmitoylated peptide in human skin
The most directly relevant published work is a 2025 report in ACS Applied Bio Materials in which researchers applied a noninvasive approach to monitor palmitoyl hexapeptide-12 across human skin layers and examined its mechanical interaction with skin components and potential skincare benefits (PMID 39964201). The study was framed around detecting and following the peptide within skin rather than around a clinical endpoint, which places it in the mechanistic and analytical end of the evidence base (PMID 39964201).
Multi-peptide technologies
A 2025 article in the Journal of Cosmetic Dermatology described developments in a peptide-based skincare approach known as TriHex Technology, presented under the heading TriHex 2.0 and discussed in terms of skin health science (PMID 39660586). Articles of this type are the usual place where hexapeptide-12 is named as one component of a defined peptide combination rather than studied on its own (PMID 39660586).
Formulation-level clinical reports
A 2022 report in the Journal of Clinical and Aesthetic Dermatology examined the effects of a topical anti-aging formulation on skin aging biomarkers, with the outcome defined at the level of the finished product rather than any individual ingredient (PMID 36061477). In a different therapeutic area, a 2022 review in the Journal of Drugs in Dermatology described a multipronged approach to pigmentation management, the kind of review context in which topical cosmetic agents are discussed alongside other modalities (PMID 36342738). Neither publication isolates a single peptide as the variable under test, and the literature as summarised here reported no head-to-head comparison of hexapeptide-12 against a matched vehicle on its own.
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appSafety Evaluation of Cosmetic Peptides: What Studies Report
Rather than adverse-event tables for one ingredient, the published record on cosmetic peptides tends to address assessment methodology. A 2026 paper in Current Research in Toxicology set out a framework for the safety evaluation of peptides in cosmetics, addressing how this class of ingredients should be approached in toxicological assessment (PMID 41953401). The existence of such a framework paper indicates that peptides as a group have been treated as a category requiring structured evaluation, and the verified literature summarised on this page reported no ingredient-specific adverse-event dataset for hexapeptide-12 (PMID 41953401). Topical cosmetic ingredients in the United States are not subject to pre-market approval in the way drug products are, so regulatory status should not be read as an evaluation of any individual sequence.
What the Name Does Not Indicate
- Not an approval status. An INCI name records nomenclature, not regulatory clearance for any indication.
- Not a potency ranking. The "-12" is a registry number.
- Not a shared mechanism with other numbered hexapeptides. Different sequences, different literature.
- Not an injectable or systemic research peptide. Published work on the term sits in topical skin science.
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeQuick Reference
| Field | Entry |
|---|---|
| Name type | INCI cosmetic ingredient name |
| Chain length | Six amino acids |
| Common modified form | Palmitoyl hexapeptide-12 (fatty-acid acylated) |
| Origin | Chemical synthesis |
| Typical research setting | Topical skin science and cosmetic dermatology |
| Key skin-layer study | PMID 39964201 (2025) |
| Combination-technology review | PMID 39660586 (2025) |
| Safety-assessment framework | PMID 41953401 (2026) |
Related Glossary Distinctions
Because numbered peptide names are easy to mix up, it helps to read them as catalogue entries. Tripeptide-1 is a three-amino-acid INCI entry frequently named in the same formulation discussions, including the technology described in the 2025 Journal of Cosmetic Dermatology article (PMID 39660586). Acetyl hexapeptide-8 is a separate six-amino-acid entry with its own literature. Nothing about sharing a length implies a shared target, shared stability, or shared evidence base.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeReferences
- Noninvasive Monitoring of Palmitoyl Hexapeptide-12 in Human Skin Layers: Mechanical Interaction with Skin Components and Its Potential Skincare Benefits (ACS Applied Bio Materials, 2025)
- TriHex 2.0-Advancing Skin Health Science and the TriHex Technology (Journal of Cosmetic Dermatology, 2025)
- Effects of a Topical Anti-aging Formulation on Skin Aging Biomarkers (The Journal of Clinical and Aesthetic Dermatology, 2022)
- Advances in Pigmentation Management: A Multipronged Approach (Journal of Drugs in Dermatology, 2022)
- A framework for the safety evaluation of peptides in cosmetics (Current Research in Toxicology, 2026)
Frequently asked questions
What does the "-12" in hexapeptide-12 mean?▾
It is a sequential registry number within cosmetic ingredient nomenclature that distinguishes one six-amino-acid entry from another. It carries no information about potency, quality, or generation. "Hexa-" indicates the six-amino-acid chain length; the number simply separates this sequence from other registered hexapeptides such as hexapeptide-8 or hexapeptide-11, which have entirely separate literatures.
Is hexapeptide-12 the same as palmitoyl hexapeptide-12?▾
They are listed as separate ingredient entries. Palmitoyl hexapeptide-12 is the same peptide backbone with a sixteen-carbon palmitic acid chain attached, which increases lipophilicity. The palmitoylated form is the one most often named in published skin-science work, including a 2025 study that monitored it noninvasively across human skin layers (PMID 39964201).
What have researchers actually measured with this peptide?▾
A 2025 report in ACS Applied Bio Materials described noninvasive monitoring of palmitoyl hexapeptide-12 within human skin layers and examined its mechanical interaction with skin components and potential skincare benefits (PMID 39964201). That work was analytical and mechanistic in framing rather than a clinical trial of a defined endpoint.
Is hexapeptide-12 studied on its own or inside formulations?▾
Mostly inside formulations. A 2025 Journal of Cosmetic Dermatology article described a peptide combination approach under the TriHex 2.0 heading (PMID 39660586), and a 2022 report evaluated a topical anti-aging formulation against skin aging biomarkers at the product level (PMID 36061477). Formulation-level designs cannot attribute results to any single ingredient.
What does the literature report about safety?▾
The verified record addresses methodology rather than one ingredient. A 2026 paper in Current Research in Toxicology proposed a framework for the safety evaluation of peptides in cosmetics, treating the class as one requiring structured toxicological assessment (PMID 41953401). No ingredient-specific adverse-event dataset for hexapeptide-12 appeared in the literature summarised here.
Is hexapeptide-12 an injectable research peptide?▾
No. The published work associated with this name sits in topical skin science and cosmetic dermatology, where it appears as a formulation ingredient rather than a systemically administered compound. Its INCI designation is a cosmetic nomenclature entry, which records chemistry and registry position only and confers no drug approval or therapeutic indication.
Does the name indicate regulatory approval?▾
No. An INCI name is a nomenclature record. In the United States, cosmetic ingredients are not subject to the pre-market approval process that applies to drug products, so the presence of a registered name says nothing about evaluation of a specific sequence. This entry is educational only and is not medical advice.
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.